| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 27.561 | 35.728 | 36.616 | 37.636 | 32.483 | 19.576 | 21.709 | 29.209 | 28.019 | 21.998 |
| Total Income - EUR | 27.561 | 35.728 | 36.616 | 37.636 | 32.483 | 20.149 | 21.709 | 29.209 | 28.065 | 21.998 |
| Total Expenses - EUR | 24.098 | 30.650 | 29.452 | 33.905 | 32.103 | 18.776 | 9.985 | 16.560 | 26.520 | 25.711 |
| Gross Profit/Loss - EUR | 3.463 | 5.078 | 7.164 | 3.731 | 380 | 1.373 | 11.723 | 12.649 | 1.546 | -3.714 |
| Net Profit/Loss - EUR | 2.168 | 4.721 | 6.498 | 3.355 | 55 | 1.101 | 11.072 | 11.773 | 1.066 | -3.714 |
| Employees | 2 | 2 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Andre-Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 13.825 | 10.107 | 6.513 | 5.334 | 5.361 | 5.378 | 5.273 | 2.278 |
| Current Assets | 20.134 | 24.066 | 23.874 | 21.744 | 17.783 | 18.700 | 27.626 | 32.757 | 32.868 | 29.576 |
| Inventories | 18.592 | 21.689 | 20.579 | 20.165 | 16.800 | 11.827 | 7.289 | 4.214 | 10.434 | 3.675 |
| Receivables | 182 | 28 | 28 | 27 | 27 | 1.000 | 3.379 | 0 | 142 | 200 |
| Cash | 1.360 | 2.348 | 3.268 | 1.552 | 956 | 5.873 | 16.958 | 28.543 | 22.293 | 25.701 |
| Shareholders Funds | 1.462 | 6.168 | 12.562 | 15.686 | 14.047 | 14.882 | 25.624 | 35.567 | 30.284 | 25.341 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 18.671 | 17.897 | 27.787 | 17.668 | 10.787 | 9.502 | 7.364 | 2.567 | 7.882 | 6.513 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4719 - 4719" | |||||||||
| CAEN Financial Year |
4719
|
|||||||||
Comments - Andre-Med S.r.l.